» Articles » PMID: 31275401

Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana

Overview
Journal J Trop Med
Publisher Wiley
Specialty Tropical Medicine
Date 2019 Jul 6
PMID 31275401
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) decreases placental parasitaemia and improves birth outcomes. Currently, WHO recommends three or more doses of SP given during antenatal care (ANC), spaced one month apart after 16 weeks of gestation till delivery. This study determined the level of uptake of SP and its association with birth outcomes in rural northern Ghana.

Methods: A survey was carried out at the War Memorial Hospital in Navrongo, Ghana, among mothers who had delivered within ten weeks and were seeking postnatal care. Data on time of first ANC, number of visits, receipt of IPTp-SP, and birth outcomes were extracted from the antenatal records of 254 mothers. Mothers were interviewed on their background characteristics and obstetric history. Chi-square tests and logistic regression were carried out to determine association between antenatal indicators, uptake of IPTp-SP, and birth outcomes using Stata version 13.

Results: Uptake of three-five doses of SP was IPT3 =76.4%, IPT4 =37.3%, and IPT5 = 16.0%. Receipt of first dose of SP at 16, 17-24, and 25-36 weeks of gestation was 16.9%, 56.7%, and 26.4%, respectively. Taking the first dose of SP during the second trimester allowed for taking ≥3 doses of SP compared to taking the first dose during the third trimester (2 = 60.1, <0.001). Women who made ≥4 visits were more likely to receive ≥3 doses of SP compared to those who made <4 visits (2 = 87.6, <0.001). Women who received ≥ 3 doses of SP were more likely (OR = 3.3; 95% CI: 1.69-6.33) to give birth at term and also have normal weight babies (OR =4.0; 95% CI: 1.98-8.06).

Conclusion: Uptake of three or more doses of SP contributed to improved pregnancy outcomes. Increased efforts towards improving early ANC attendance could increase uptake of SP and improve pregnancy outcomes.

Citing Articles

Individual- and community-level correlates of intermittent preventive treatment of malaria in pregnancy in Ghana: further analysis of the 2019 Malaria Indicator Survey.

Sarfo J, Doe P, Mireku D Res Health Serv Reg. 2024; 3(1):22.

PMID: 39714570 PMC: 11666873. DOI: 10.1007/s43999-024-00058-6.


Knowledge, and attitude of service user of intermittent preventive treatment of malaria in pregnancy using sulfadoxine pyrimethamine in the Volta Region of Ghana.

Asem L, Abdulia A, Assuming P, Abeka-Nkrumah G PLoS One. 2024; 19(9):e0309340.

PMID: 39240950 PMC: 11379158. DOI: 10.1371/journal.pone.0309340.


The demand for intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine in the Volta Region of Ghana.

Asem L, Abdulia A, Assuming P, Abeka-Nkrumah G PLoS One. 2024; 19(9):e0308321.

PMID: 39236029 PMC: 11376531. DOI: 10.1371/journal.pone.0308321.


Prevalence and determinants of malaria infection among pregnant women attending antenatal clinic in Ejisu government hospital in Ghana: A cross-sectional study.

Dwumfour C, Bam V, Owusu L, Poku C, Kpabitey R, Aboagye P PLoS One. 2023; 18(10):e0293420.

PMID: 37903177 PMC: 10615274. DOI: 10.1371/journal.pone.0293420.


Interventions for malaria prevention in pregnancy; factors influencing uptake and their effect on pregnancy outcomes among post-natal women in a tertiary facility in the Volta Region of Ghana.

Ampofo G, Ahiakpa A, Osarfo J SAGE Open Med. 2023; 11:20503121231199653.

PMID: 37719169 PMC: 10503280. DOI: 10.1177/20503121231199653.


References
1.
Oduro A, Fryauff D, Koram K, Rogers W, Anto F, Atuguba F . Sulfadoxine-pyrimethamine-based intermittent preventive treatment, bed net use, and antenatal care during pregnancy: demographic trends and impact on the health of newborns in the Kassena Nankana District, northeastern Ghana. Am J Trop Med Hyg. 2010; 83(1):79-89. PMC: 2912580. DOI: 10.4269/ajtmh.2010.10-0066. View

2.
Mbengue M, Bei A, Mboup A, Ahouidi A, Sarr M, Mboup S . Factors influencing the use of malaria prevention strategies by women in Senegal: a cross-sectional study. Malar J. 2017; 16(1):470. PMC: 5697112. DOI: 10.1186/s12936-017-2095-2. View

3.
Ejeta E, Dabsu R, Zewdie O, Merdassa E . Factors determining late antenatal care booking and the content of care among pregnant mother attending antenatal care services in East Wollega administrative zone, West Ethiopia. Pan Afr Med J. 2017; 27:184. PMC: 5579454. DOI: 10.11604/pamj.2017.27.184.10926. View

4.
Mace K, Chalwe V, Katalenich B, Nambozi M, Mubikayi L, Mulele C . Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Malar J. 2015; 14:69. PMC: 4327785. DOI: 10.1186/s12936-015-0576-8. View

5.
Fagbamigbe A, Mashabe B, Lepetu L, Abel C . Are the timings and risk factors changing? Survival analysis of timing of first antenatal care visit among pregnant women in Nigeria (2003-2013). Int J Womens Health. 2017; 9:807-819. PMC: 5669794. DOI: 10.2147/IJWH.S138329. View